HER2 overexpression predicts survival in stage II and III of breast cancer patients treated with neoadjuvant docetaxel plus epirubicin (2005)
- Authors:
- USP affiliated authors: ANDRADE, JURANDYR MOREIRA DE - FMRP ; SILVA, ALFREDO RIBEIRO DA - FMRP
- Unidade: FMRP
- Subjects: NEOPLASIAS MAMÁRIAS; BIOMARCADORES
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2005
- Source:
- Título: Virchous Archiv
- ISSN: 0945-6317
- Volume/Número/Paginação/Ano: v. 447, n. 2, p. 364, res. P418, 2005
- Conference titles: European Congress of Pathology
-
ABNT
TIEZZI, Daniel Guimarães et al. HER2 overexpression predicts survival in stage II and III of breast cancer patients treated with neoadjuvant docetaxel plus epirubicin. Virchous Archiv. Heidelberg: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 19 nov. 2024. , 2005 -
APA
Tiezzi, D. G., Andrade, J. M. de, Ribeiro-Silva, A., Tiezzi, M. G., Marana, H. R. C., Zola, F. E., & Sarmento-Filho, J. M. (2005). HER2 overexpression predicts survival in stage II and III of breast cancer patients treated with neoadjuvant docetaxel plus epirubicin. Virchous Archiv. Heidelberg: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Tiezzi DG, Andrade JM de, Ribeiro-Silva A, Tiezzi MG, Marana HRC, Zola FE, Sarmento-Filho JM. HER2 overexpression predicts survival in stage II and III of breast cancer patients treated with neoadjuvant docetaxel plus epirubicin. Virchous Archiv. 2005 ; 447( 2): 364.[citado 2024 nov. 19 ] -
Vancouver
Tiezzi DG, Andrade JM de, Ribeiro-Silva A, Tiezzi MG, Marana HRC, Zola FE, Sarmento-Filho JM. HER2 overexpression predicts survival in stage II and III of breast cancer patients treated with neoadjuvant docetaxel plus epirubicin. Virchous Archiv. 2005 ; 447( 2): 364.[citado 2024 nov. 19 ] - HER2 overexpression predicts survival in stage II and III breast cancer patients treated with neoadjuvant docetaxel plus epirubicin
- HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination
- Metastases to the breast from extramammary malignancies: a clinicopathologic study of 12 cases with review of the literature
- Metastases to the breast from extramammary malignancies: a clinicopathologic study of 12 cases
- Metastases to the breast from extramammary malignancies: a clinicopathologic study of 12 cases and review of the literature
- HER2 overexpression predicts survival in stage II and III breast cancer patients treated with neoadjuvant docetaxel plus epirubicin
- Apoptosis induced by neodjuvant chemotherapy in breast cancer
- Induction of apoptosis predicts response to neoadjuvant chemotherapy in locally advanced breast cancer
- Tumor infiltrating lymphocytes are related to lymph node metastasis in patients with T1-T2 breast cancer
- Induction of apoptosis predicts response to neoadjuvant chemotherapy in locally advanced breast cancer
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
